Batumi

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Melanoma

Running trials

• Recruiting

  Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

  NCT07476326· Phase 1· Biocon Biologics UK PLC· Source

  Contact: Dr. Gursharan Singh, MBBS; PhD Pharm Med; LLM-IP

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Melanoma1 recruiting